In a new Work Comp Wire article, Chief Sales Officer David Dubrof discusses how strong pharmacy network relationships and clinical oversight are more important for a long-term claims management strategy.
Newly appointed myMatrixx Chief Sales Officer, David Dubrof, was featured in the most recent edition of Work Comp Wire’s Leaders Speak series, where he discussed emerging industry pricing trends. The article, “PBM Price Transparency — What You See Isn’t Always What You Get” covered the practice of some newer entrants promoting themselves as using “transparent” pricing models. He stresses that although transparency is an important topic that payers should be concerned about, it should never come at the expense of the larger claims strategy.
Dubrof explains that while some of these programs may promise to deliver a lower price per pill or rebate savings on certain medications, there are also many hidden costs in the form of administrative fees, lower generic efficiency and unnecessary prescriptions. Additionally, smaller PBMs are often unable to provide the level of service or clinical oversight compared to more established organizations like myMatrixx, leading to increased costs and risk exposure in the long run.
This is the first part of a two part series, with Senior Vice President of Account Management, Elijah Marentette, continuing the discussion next week.